VRUS update for forward long term view - HOLDING here and

New Post Public Reply Private Reply Replies (0) Message Board
NotRichYet2
1,180
VRUS update for forward long term view - HOLDING here and ADDING

1.) VRUS won't/isn't moving on news anymore.


2.) We are being penalized b/c we are legit OTC company.

I feel like everyone missed the signal through all the noise in the last week while we sold off to the .014ish area. On monday, VRUS releases a monster PR that shows a detailed 5 year plan for a path to 400M in revenue with a 20% net margin -- that's 100 millys in profit if you don't have a calculator out! Not to mention on this path to 400M in revenue, it required ZERO dilution and its performance based, meaning US shareholders took no collateral damage or risk from this deal. If they perform VRUS is generating half-a-billion in revenue, if they don't or they don't perform up to the business plan then we have lost nothing.

So, lets disregard any multiplier at this point and go straight off the business plan - without any adjustments to the share structure this deal alone puts us trading in the 20 cent range. Now, you factor in the french fry deal, and BLF and we are firmly at the half billion range and possibly at the 3/4 billion range....so 30-35 cents???

Okay now i'm going to hit yall with a little info from Mark in an email i sent him on Tuesday:

"Nutribrands is part branded product company, part distributor, but it is Brazil based. Most of the product is sourced in the U.S. They needed funds to really expand, so Verus's new revolver can be used to kick up their growth rate. In particular, the Vivamil energy shot (which is the leading five-hour-energy type product in Brazil) has tremendous potential. This was just one of multiple deals in work. As mentioned in the last call, Verus had more than one late stage M&A deal in play."

So key take aways here:

1.) Nutribrand just needed VRUS to provide capital to ramp up sales - meaning they probably already have contracts, agreements, and demand -- simply put, the revenues are coming.

2.)Vivamil = 5 hour energy for Brazil. Let that sink in. Every gas station, every grocery store. I will also provide this snippet of research:

"Brazil’s energy drink market was valued at USD 2.23 billion in 2017 and the market is expected to register a CAGR of 9.4% during the forecast period, (2018-2023)"

We capture 1% that's $23M a year.....

They also produce "Stacker 2" -- which you have seen "Stacker" in gas stations in the US right next to the cash register.

Last, but not least, Garnock is involved in a Nutraceutical business (Disruption Labs) that we have all wondered 24/7 how it ties into VRUS....THEN... lol...VRUS goes and negotiates a deal for a controlling interest in a INTERNATIONAL NUTRACEUTICAL business and people have spent the past week worried.....??? This was the deal we have been waiting months and months for and NO ONE IS FOCUSED ON IT!!!! They are worried about MONAKER.

3.) Most of the product is sourced in the US. To me this is huge from Mark -- if Nutribrands sources their products from the US that means they are produced in manufacturing facilities that meet ISO, FDA, etc etc requirements. Meaning - VRUS can help grow this partnership and help this Brazilian company expand further into the US market b/c the products ALREADY meet the requirements to be sold here -- inspection, testing etc. It would be more difficult if they were produced in a South American factory...trying to get into the US.

4.) "VRUS had more than 1 late stage acquisition in play" -- to me, he's basically saying, stay tuned...there is more to come.... is there anything else that needs to be said????

Okay --- Now take all of that goodness and lets talk about what Coachshot was saying. VRUS is not moving on news anymore - its not because the news isn't amazing! I just spent the first part of this post showing you that VRUS -in the coming years- has already set themselves up to generating a half a billion to a billion dollars of revenue. VRUS is going to move on results - which are quarter over quarter execution. In this way, we are being penalized for not being some hyped company...the SP will grow exponentially as quarterly results and 10Ks are filed.

I guess the point of all of this is that here we sit at .015, but Anshu has already provided a detailed and basically RISK FREE path to a billion dollar company --- said in a different way -- the PRs that have already come out put this trading at .30-.45...so you have free money staring you in the face.

Then the last part -- its all about execution. What I would say is that do you think Anshu has crafted these PERFORMANCE BASED deals without giving away equity (dilution) for VRUS not to execute?? All the parties involved are incentivized to do just that -- execute. If they don't execute and succeed then they don't get PAID! That is a huge bargaining chip and its what the best companies do correctly!

Last part I'll address is the Monaker part. Okay Monaker is selling their shares b/c they need cash flow b/c the want to launch a product. Great, they have 100m shares. Ummmm.....GARNOCK OWNS 1 BILLION SHARES. Okay, go back...read that again. You are worried about a failing company liquidating 1/10th of Garnocks position???? Let me try this a different way....YOU DON'T BUY 1 BILLION SHARES TO SELL THEM at .01, .015, .02 ....there is something else going on here and its real. If you dont think its real or need a reminder read the above post again, go read all the DD again...see if it all points in the same direction.

My business school statistics prof would always say - "there are no coincidences in life." His example, bumping into someone you know at a store -- people are like its a coincidence! When you do the math the actual probability is like 25% or something...so no coincidence in life.

Okay so do the probability here of a very successful dude owning 1 Billion shares in a company that is being laid out and crafted to be 100% legit, with big board fundamentals, extremely successful leaders, and big board resources, taking all the proper steps to facilitate business (LOCs, Credit Insurance etc)....acquiring companies via zero dilution, with performance based-sound business plans, with turn-key products, in the largest growing markets in the world (Middle East, Brazil, Ice Cream, CBD, Nutraceuticals).....NONE of this is a coincidence.

The shares you are looking at right now seem to be worth .015 - in all actuality they are already worth 20x-30x that if you are -like Mark said- able to read between the lines....or just read the damn lines themselves.

Accumulate everything you can within reason based on your own financial status and sit patiently for the quarterly filings - like Coachshot said - because this is a real company and they only reason we arent trading where we should be is b/c the OTC is a hype machine. However, the fact remains, this company and all of the "COINCIDENCES" will make it to the big boards based on fundamental in time......JUST SIT BACK FOR THE RIDE.

1.) VRUS won't/isn't moving on news anymore.


2.) We are being penalized b/c we are legit OTC company.

I feel like everyone missed the signal through all the noise in the last week while we sold off to the .014ish area. On monday, VRUS releases a monster PR that shows a detailed 5 year plan for a path to 400M in revenue with a 20% net margin -- that's 100 millys in profit if you don't have a calculator out! Not to mention on this path to 400M in revenue, it required ZERO dilution and its performance based, meaning US shareholders took no collateral damage or risk from this deal. If they perform VRUS is generating half-a-billion in revenue, if they don't or they don't perform up to the business plan then we have lost nothing.

So, lets disregard any multiplier at this point and go straight off the business plan - without any adjustments to the share structure this deal alone puts us trading in the 20 cent range. Now, you factor in the french fry deal, and BLF and we are firmly at the half billion range and possibly at the 3/4 billion range....so 30-35 cents???

Okay now i'm going to hit yall with a little info from Mark in an email i sent him on Tuesday:

"Nutribrands is part branded product company, part distributor, but it is Brazil based. Most of the product is sourced in the U.S. They needed funds to really expand, so Verus's new revolver can be used to kick up their growth rate. In particular, the Vivamil energy shot (which is the leading five-hour-energy type product in Brazil) has tremendous potential. This was just one of multiple deals in work. As mentioned in the last call, Verus had more than one late stage M&A deal in play."

So key take aways here:

1.) Nutribrand just needed VRUS to provide capital to ramp up sales - meaning they probably already have contracts, agreements, and demand -- simply put, the revenues are coming.

2.)Vivamil = 5 hour energy for Brazil. Let that sink in. Every gas station, every grocery store. I will also provide this snippet of research:

"Brazil’s energy drink market was valued at USD 2.23 billion in 2017 and the market is expected to register a CAGR of 9.4% during the forecast period, (2018-2023)"

We capture 1% that's $23M a year.....

They also produce "Stacker 2" -- which you have seen "Stacker" in gas stations in the US right next to the cash register.

Last, but not least, Garnock is involved in a Nutraceutical business (Disruption Labs) that we have all wondered 24/7 how it ties into VRUS....THEN... lol...VRUS goes and negotiates a deal for a controlling interest in a INTERNATIONAL NUTRACEUTICAL business and people have spent the past week worried.....??? This was the deal we have been waiting months and months for and NO ONE IS FOCUSED ON IT!!!! They are worried about MONAKER.

3.) Most of the product is sourced in the US. To me this is huge from Mark -- if Nutribrands sources their products from the US that means they are produced in manufacturing facilities that meet ISO, FDA, etc etc requirements. Meaning - VRUS can help grow this partnership and help this Brazilian company expand further into the US market b/c the products ALREADY meet the requirements to be sold here -- inspection, testing etc. It would be more difficult if they were produced in a South American factory...trying to get into the US.

4.) "VRUS had more than 1 late stage acquisition in play" -- to me, he's basically saying, stay tuned...there is more to come.... is there anything else that needs to be said????

Okay --- Now take all of that goodness and lets talk about what Coachshot was saying. VRUS is not moving on news anymore - its not because the news isn't amazing! I just spent the first part of this post showing you that VRUS -in the coming years- has already set themselves up to generating a half a billion to a billion dollars of revenue. VRUS is going to move on results - which are quarter over quarter execution. In this way, we are being penalized for not being some hyped company...the SP will grow exponentially as quarterly results and 10Ks are filed.

I guess the point of all of this is that here we sit at .015, but Anshu has already provided a detailed and basically RISK FREE path to a billion dollar company --- said in a different way -- the PRs that have already come out put this trading at .30-.45...so you have free money staring you in the face.

Then the last part -- its all about execution. What I would say is that do you think Anshu has crafted these PERFORMANCE BASED deals without giving away equity (dilution) for VRUS not to execute?? All the parties involved are incentivized to do just that -- execute. If they don't execute and succeed then they don't get PAID! That is a huge bargaining chip and its what the best companies do correctly!

Last part I'll address is the Monaker part. Okay Monaker is selling their shares b/c they need cash flow b/c the want to launch a product. Great, they have 100m shares. Ummmm.....GARNOCK OWNS 1 BILLION SHARES. Okay, go back...read that again. You are worried about a failing company liquidating 1/10th of Garnocks position???? Let me try this a different way....YOU DON'T BUY 1 BILLION SHARES TO SELL THEM at .01, .015, .02 ....there is something else going on here and its real. If you dont think its real or need a reminder read the above post again, go read all the DD again...see if it all points in the same direction.

My business school statistics prof would always say - "there are no coincidences in life." His example, bumping into someone you know at a store -- people are like its a coincidence! When you do the math the actual probability is like 25% or something...so no coincidence in life.

Okay so do the probability here of a very successful dude owning 1 Billion shares in a company that is being laid out and crafted to be 100% legit, with big board fundamentals, extremely successful leaders, and big board resources, taking all the proper steps to facilitate business (LOCs, Credit Insurance etc)....acquiring companies via zero dilution, with performance based-sound business plans, with turn-key products, in the largest growing markets in the world (Middle East, Brazil, Ice Cream, CBD, Nutraceuticals).....NONE of this is a coincidence.

The shares you are looking at right now seem to be worth .015 - in all actuality they are already worth 20x-30x that if you are -like Mark said- able to read between the lines....or just read the damn lines themselves.

Accumulate everything you can within reason based on your own financial status and sit patiently for the quarterly filings - like Coachshot said - because this is a real company and they only reason we arent trading where we should be is b/c the OTC is a hype machine. However, the fact remains, this company and all of the "COINCIDENCES" will make it to the big boards based on fundamental in time......JUST SIT BACK FOR THE RIDE.

1.) VRUS won't/isn't moving on news anymore.


2.) We are being penalized b/c we are legit OTC company.

I feel like everyone missed the signal through all the noise in the last week while we sold off to the .014ish area. On monday, VRUS releases a monster PR that shows a detailed 5 year plan for a path to 400M in revenue with a 20% net margin -- that's 100 millys in profit if you don't have a calculator out! Not to mention on this path to 400M in revenue, it required ZERO dilution and its performance based, meaning US shareholders took no collateral damage or risk from this deal. If they perform VRUS is generating half-a-billion in revenue, if they don't or they don't perform up to the business plan then we have lost nothing.

So, lets disregard any multiplier at this point and go straight off the business plan - without any adjustments to the share structure this deal alone puts us trading in the 20 cent range. Now, you factor in the french fry deal, and BLF and we are firmly at the half billion range and possibly at the 3/4 billion range....so 30-35 cents???

Okay now i'm going to hit yall with a little info from Mark in an email i sent him on Tuesday:

"Nutribrands is part branded product company, part distributor, but it is Brazil based. Most of the product is sourced in the U.S. They needed funds to really expand, so Verus's new revolver can be used to kick up their growth rate. In particular, the Vivamil energy shot (which is the leading five-hour-energy type product in Brazil) has tremendous potential. This was just one of multiple deals in work. As mentioned in the last call, Verus had more than one late stage M&A deal in play."

So key take aways here:

1.) Nutribrand just needed VRUS to provide capital to ramp up sales - meaning they probably already have contracts, agreements, and demand -- simply put, the revenues are coming.

2.)Vivamil = 5 hour energy for Brazil. Let that sink in. Every gas station, every grocery store. I will also provide this snippet of research:

"Brazil’s energy drink market was valued at USD 2.23 billion in 2017 and the market is expected to register a CAGR of 9.4% during the forecast period, (2018-2023)"

We capture 1% that's $23M a year.....

They also produce "Stacker 2" -- which you have seen "Stacker" in gas stations in the US right next to the cash register.

Last, but not least, Garnock is involved in a Nutraceutical business (Disruption Labs) that we have all wondered 24/7 how it ties into VRUS....THEN... lol...VRUS goes and negotiates a deal for a controlling interest in a INTERNATIONAL NUTRACEUTICAL business and people have spent the past week worried.....??? This was the deal we have been waiting months and months for and NO ONE IS FOCUSED ON IT!!!! They are worried about MONAKER.

3.) Most of the product is sourced in the US. To me this is huge from Mark -- if Nutribrands sources their products from the US that means they are produced in manufacturing facilities that meet ISO, FDA, etc etc requirements. Meaning - VRUS can help grow this partnership and help this Brazilian company expand further into the US market b/c the products ALREADY meet the requirements to be sold here -- inspection, testing etc. It would be more difficult if they were produced in a South American factory...trying to get into the US.

4.) "VRUS had more than 1 late stage acquisition in play" -- to me, he's basically saying, stay tuned...there is more to come.... is there anything else that needs to be said????

Okay --- Now take all of that goodness and lets talk about what Coachshot was saying. VRUS is not moving on news anymore - its not because the news isn't amazing! I just spent the first part of this post showing you that VRUS -in the coming years- has already set themselves up to generating a half a billion to a billion dollars of revenue. VRUS is going to move on results - which are quarter over quarter execution. In this way, we are being penalized for not being some hyped company...the SP will grow exponentially as quarterly results and 10Ks are filed.

I guess the point of all of this is that here we sit at .015, but Anshu has already provided a detailed and basically RISK FREE path to a billion dollar company --- said in a different way -- the PRs that have already come out put this trading at .30-.45...so you have free money staring you in the face.

Then the last part -- its all about execution. What I would say is that do you think Anshu has crafted these PERFORMANCE BASED deals without giving away equity (dilution) for VRUS not to execute?? All the parties involved are incentivized to do just that -- execute. If they don't execute and succeed then they don't get PAID! That is a huge bargaining chip and its what the best companies do correctly!

Last part I'll address is the Monaker part. Okay Monaker is selling their shares b/c they need cash flow b/c the want to launch a product. Great, they have 100m shares. Ummmm.....GARNOCK OWNS 1 BILLION SHARES. Okay, go back...read that again. You are worried about a failing company liquidating 1/10th of Garnocks position???? Let me try this a different way....YOU DON'T BUY 1 BILLION SHARES TO SELL THEM at .01, .015, .02 ....there is something else going on here and its real. If you dont think its real or need a reminder read the above post again, go read all the DD again...see if it all points in the same direction.

My business school statistics prof would always say - "there are no coincidences in life." His example, bumping into someone you know at a store -- people are like its a coincidence! When you do the math the actual probability is like 25% or something...so no coincidence in life.

Okay so do the probability here of a very successful dude owning 1 Billion shares in a company that is being laid out and crafted to be 100% legit, with big board fundamentals, extremely successful leaders, and big board resources, taking all the proper steps to facilitate business (LOCs, Credit Insurance etc)....acquiring companies via zero dilution, with performance based-sound business plans, with turn-key products, in the largest growing markets in the world (Middle East, Brazil, Ice Cream, CBD, Nutraceuticals).....NONE of this is a coincidence.

The shares you are looking at right now seem to be worth .015 - in all actuality they are already worth 20x-30x that if you are -like Mark said- able to read between the lines....or just read the damn lines themselves.

Accumulate everything you can within reason based on your own financial status and sit patiently for the quarterly filings - like Coachshot said - because this is a real company and they only reason we arent trading where we should be is b/c the OTC is a hype machine. However, the fact remains, this company and all of the "COINCIDENCES" will make it to the big boards based on fundamental in time......JUST SIT BACK FOR THE RIDE.

Verus International, Inc. (VRUS) Stock Research Links

VRUS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCOM Secures $600M Deal to Boost NATO's Defense

Updated Category News Views 3

TCOM's Pivotal $600 Million Defense Contract How often do you hear about a deal north of $600 million that practically revamps a company's strategic future? That's precisely what's hitting the books at TCOM right now. They've scored a heavy-hitting Foreign Military Sales (FMS) contract to fortify NATO's eastern front with Poland. I'll tell you this—it’s one of the...

Continue Reading
Epson & The Photo Managers Highlight Memories in Sept.

Updated Category News Views 8

A Focus on Memory Preservation I remember a time when you kept memories in photo albums, dusty boxes in basements. Now, folks aim to digitize those moments before they're lost forever. With September here, Epson and The Photo Managers are telling us it's time for action. And hey, the campaign’s got a catchy name, 'One Photo, One Story.' Simple, yet it urges us all to...

Continue Reading
Zum Drivers Shine as New School Year Begins

Updated Category News Views 0

Opening the School Year with High Hopes Zum's crew of enthusiastic drivers hit the streets with a mission: kickstarting the new school year with a sense of excitement that feels fresh, even to a grizzled trader like me. These folks are doing more than just turning the ignition, they’re handling a vital cog in the education machine. From Fresno down to Rockford, you’ll...

Continue Reading
MacGregor's Bold Play: RoRo Tech for TT-Line's Ferries

Updated Category News Views 2

A Green Wave in the Baltic It looks like MacGregor's betting big on the future of maritime transport, and they're putting their chips down on TT-Line's next-gen battery-hybrid LNG ferries. With a contract fresh out of the oven, they've signed up to kit out these eco-warriors with a range of RoRo equipment. And let me tell you, this is no piddly order—by any stretch,...

Continue Reading
Supercharged Entertainment's Big Bet in Ohio's Polaris

Updated Category News Views 0

Fasten your seatbelts, folks—because there's a tinge of burnt rubber in the air at Columbus's Polaris Center. Supercharged Entertainment, the big guns in indoor karting, just kicked off construction at their brand-new venue, and it’s looking like a gearhead's paradise. A sprawling 16-acre parcel is set to become a haven for adrenaline junkies come Summer 2027. A Bold...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 1

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
Axjo Group Expands in France with Eco-Tourets Buy

Updated Category News Views 6

Seizing the French Market: Axjo's Strategic Play Every now and then, you come across a company that's not just talking the talk but walking the green walk. Axjo Group's latest move—scooping up France's Eco-Tourets—puts them squarely in that league. It ain't just about expanding the footprint; it's about owning a piece of the future where sustainability isn't a...

Continue Reading
Tradr's Bold Venture: Anthropic ETFs Ahead of IPO

Updated Category News Views 2

Why Tradr Is Diving Into Anthropic's Hype There's a whiff of anticipation in the air as Anthropic gears up for its much-anticipated IPO, and Tradr isn't sitting on its hands here. They've just filed for two ETFs—one long, one short—ahead of the big day. We're talking about ANTT and ANTZ, betting on leveraged and inverse plays on whatever whirlwind Anthropic's stock...

Continue Reading
Early Education's Massive Impact: Key Skills for Success

Updated Category News Views 2

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Continue Reading
Innventure Faces Class Action Over Alleged Deception

Updated Category News Views 3

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...

Continue Reading

Top 5 Most Recently Viewed Articles

Zealand Pharma A/S Updates Share Count and Voting Rights

Updated Category News Views 86

Zealand Pharma A/S, a key player in the biotech sector out of Copenhagen, confirmed back in early 2024 that it had a total of 71,023,871 shares outstanding. Each share carries a nominal value of DKK 1. This number isn’t just a footnote—it’s vital for any stakeholder keeping tabs on their stake or those considering diving into this space. The company’s compliance...

Continue Reading
CS Genetics Introduces Innovative SimpleCell™ Genomics Kits

Updated Category News Views 146

CS Genetics Launches SimpleCell™ for Enhanced Single-Cell Genomics Single-cell genomics has entered a new era with the exciting launch of SimpleCell™ 3' Gene Expression kits by CS Genetics, a pioneer in the field. This innovative platform simplifies the process of single-cell transcriptomics, making it more accessible and scalable than ever before. The Power of...

Continue Reading
LifeMD's Engagement at the Upcoming Growth Conference

Updated Category News Views 117

LifeMD's Participation in a Major Growth Conference LifeMD, Inc. (Nasdaq: LFMD), a prominent provider in the domain of virtual primary healthcare, has announced its upcoming participation in the Canaccord Genuity 45th Annual Growth Conference. This well-regarded event will take place from August 12 to 14, offering a dynamic platform for dialogue between investors and...

Continue Reading
Exploring Embedded Finance in India: Growth Forecasts to 2029

Updated Category News Views 306

The Future of Embedded Finance in India The embedded finance industry in India is on a remarkable growth trajectory. As we look ahead to the years leading up to 2029, projections indicate a compound annual growth rate (CAGR) of 37.8%, with revenue climbing from US$5.75 billion in 2024 to an impressive US$28.6 billion by the end of the forecast period. Transformative...

Continue Reading
Revolutionizing 3D Modeling: Fixstars Unveils CUMVS Software

Updated Category News Views 179

Revolutionizing 3D Modeling with CUMVS Software Fixstars Corporation, a leader in AI-driven software development, recently made waves with the open-source release of its groundbreaking software, CUMVS (cuda-multi-view-stereo), designed for rapid 3D model generation from 2D images. This innovative software allows users to create digital twins of real-world objects, marking...

Continue Reading